The T2Bacteria Panel is a rapid detector of bacteremia and has potential to guide therapy in patients with hematological malignancies and hematopoietic stem cell transplantation (HSCT): a pilot study of non-culture molecular diagnostics
The T2Bacteria assay is a sensitive and rapid detector of bacteremia that can be initiated in the emergency department and has potential to favorably influence subsequent therapy
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study
Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood
Accuracy of T2MR in diagnosing candidemia in critically ill patients: a prospective observational study
T2Candida® to guide antifungal and length of treatment of candidemia in a pediatric multivisceral transplant recipient
Implementation of the T2 Biosystems T2Bacteria Panel in a level-one trauma center, safety net hospital
Incorporating T2Candida testing into rational antifungal (AF) management: A successful pilot study of diagnostic stewardship directed toward specific intensive care unit patients at-risk for sepsis due to invasive candidiasis